The much-anticipated sequel, Awarapan 2, is now slated for a release in May or June 2026. Producer Mukesh Bhatt has clarified the reasons behind this date adjustment, firmly refuting reports that the postponement was driven by competition from other major releases like Dhurandhar 2 and Toxic. Bhatt emphasized that the decision is rooted in practical production challenges rather than strategic box office avoidance.
Emraan Hashmi's Accident: The Real Cause of Delay Mukesh Bhatt revealed the primary reason for the delay, directly addressing the health of the film's lead actor. * On-Set Injury: While shooting for Awarapan 2, Emraan Hashmi met with an accident that necessitated surgery. * Action Restriction: Post-surgery, Hashmi has been advised a 45-day recovery period during which he is unable to perform action sequences. This directly impacts the remaining shoot schedule. * Remaining Schedule: Only one schedule, approximately 20 days of shooting in Malaysia, remains for the film's completion. This crucial block of work, including key action sequences, will be undertaken once Emraan Hashmi's medical rest period concludes.
No Fear of Box Office Clashes, Says Bhatt Dispelling rumors of competition influencing the release date, Mukesh Bhatt stated, “I’m not scared of Dhurandhar 2 and Toxic.” This clarifies that the delay is solely due to the actor's recovery and the subsequent adjustments in the production timeline.
About Awarapan 2 The sequel follows the critically acclaimed 2007 action-romance drama Awarapan, which earned a significant cult following for its intense narrative and Emraan Hashmi’s powerful performance. The upcoming film reunites Hashmi with director Nitin Kakkar and writer Bilal Siddiqui, with Disha Patani and veteran actress Shabana Azmi also reported to be in prominent roles.
